MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
147.25
-1.28
-0.86%
Opening 15:22 04/25 EDT
OPEN
149.37
PREV CLOSE
148.53
HIGH
149.58
LOW
146.33
VOLUME
4.86M
TURNOVER
0
52 WEEK HIGH
175.97
52 WEEK LOW
142.71
MARKET CAP
354.84B
P/E (TTM)
9.18
1D
5D
1M
3M
1Y
5Y
Bert's March Dividend Income Summary
March is one of the lower months for SCHD for dividend payments. Realty Income has been one of my top stock buys in 2024. My wife and I earned almost $5,000 in passive income this month. 59% of our March Dividend Income came from funds.
Seeking Alpha · 5h ago
Guru Fundamental Report for JNJ
NASDAQ · 10h ago
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys. Global stock indices continued an upward trend in March, with both U.S. Stocks rising by 3%. Nvidia unveiled its groundbreaking Blackwell chip at GTC 2024. The S&P 500 recorded its longest positive monthly streak since 2021.
Seeking Alpha · 11h ago
LLY vs. JNJ: Which Big Pharma Stock Is Better?
I evaluated two big pharma stocks, Eli Lilly and Johnson & Johnson, using TipRanks’ Comparison Tool. Shares of Eli Lilly have surged 26% year-to-date and are up 92% over the last 12 months. A neutral view for Eli Lilly suggests a bullish view for Johnson and Johnson. Eli Lilly is trading at a much higher valuation than JNJ.
TipRanks · 19h ago
Will Higher Keytruda Sales Drive Merck's Q1
NASDAQ · 21h ago
Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset
Shares of Cidara Therapeutics are up 42% in after-hours trading. The company divested a candidiasis treatment to its partner and bought back the rights to an influenza-prevention treatment. The stock is up roughly 15-fold since the start of the year.
Dow Jones · 1d ago
Cidara Therapeutics Reacquires Global Development And Commercial Rights To CD388 From Johnson & Johnson For A One Time Payment Of $85M; Announces Private Placement Financing Of $240M
Cidara Therapeutics, Inc. Has entered into a definitive agreement with Johnson & Johnson to reacquire the exclusive global development and commercial rights to CD388. $240 million private placement financing led by RA Capital Management to fund Phase 2b clinical trial. CD388 is in development for the prevention of all strains of influenza A and B.
Benzinga · 1d ago
Cidara stock rallies amid $240M private placement, drug update
Shares of Cidara Therapeutics rallied 25% in post-market trading. The company announced it had reacquired rights to its antiviral drug CD388 from Johnson & Johnson. The drug is being developed as a treatment for influenza A and B. J&J also agreed to a $240M private placement of the company's stock.
Seeking Alpha · 1d ago
More
About JNJ
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.